Focus Partners Wealth Trims Stake in Healthpeak Properties, Inc. (NYSE:DOC)

Focus Partners Wealth reduced its position in Healthpeak Properties, Inc. (NYSE:DOC) by 42.3% during the fourth quarter, HoldingsChannel.com reports. The firm owned 52,282 shares of the real estate investment trust’s stock after selling 38,304 shares during the period. Focus Partners Wealth’s holdings in Healthpeak Properties were worth $1,060,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in DOC. Principal Financial Group Inc. raised its position in Healthpeak Properties by 2,113.5% in the 4th quarter. Principal Financial Group Inc. now owns 18,133,812 shares of the real estate investment trust’s stock worth $367,575,000 after purchasing an additional 17,314,572 shares during the period. Norges Bank purchased a new stake in Healthpeak Properties in the 4th quarter worth about $166,804,000. Long Pond Capital LP bought a new position in Healthpeak Properties in the 4th quarter worth about $86,885,000. JPMorgan Chase & Co. grew its stake in Healthpeak Properties by 23.2% in the 3rd quarter. JPMorgan Chase & Co. now owns 21,561,640 shares of the real estate investment trust’s stock worth $493,115,000 after acquiring an additional 4,056,931 shares in the last quarter. Finally, Northern Trust Corp grew its stake in Healthpeak Properties by 32.6% in the 4th quarter. Northern Trust Corp now owns 10,526,223 shares of the real estate investment trust’s stock worth $213,367,000 after acquiring an additional 2,590,530 shares in the last quarter. 93.57% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other news, Director John T. Thomas bought 4,200 shares of the firm’s stock in a transaction that occurred on Monday, April 28th. The stock was bought at an average price of $17.84 per share, with a total value of $74,928.00. Following the completion of the transaction, the director now directly owns 813,566 shares of the company’s stock, valued at approximately $14,514,017.44. The trade was a 0.52% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Tommy G. Thompson bought 5,700 shares of the firm’s stock in a transaction that occurred on Friday, May 9th. The shares were purchased at an average cost of $17.36 per share, with a total value of $98,952.00. Following the transaction, the director now directly owns 138,513 shares of the company’s stock, valued at $2,404,585.68. The trade was a 4.29% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last ninety days, insiders have acquired 23,987 shares of company stock worth $422,141. Corporate insiders own 0.23% of the company’s stock.

Healthpeak Properties Price Performance

NYSE DOC opened at $17.72 on Friday. The company has a debt-to-equity ratio of 0.96, a quick ratio of 1.35 and a current ratio of 1.35. The firm’s 50 day moving average price is $18.78 and its 200-day moving average price is $20.06. Healthpeak Properties, Inc. has a 52-week low of $16.90 and a 52-week high of $23.26. The company has a market cap of $12.31 billion, a PE ratio of 50.62, a P/E/G ratio of 2.17 and a beta of 1.05.

Healthpeak Properties (NYSE:DOC) last released its quarterly earnings data on Thursday, April 24th. The real estate investment trust reported $0.46 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.46. Healthpeak Properties had a net margin of 9.00% and a return on equity of 2.61%. The firm had revenue of $702.89 million for the quarter, compared to the consensus estimate of $690.76 million. During the same period last year, the firm earned $0.45 earnings per share. The company’s quarterly revenue was up 15.9% on a year-over-year basis. Sell-side analysts forecast that Healthpeak Properties, Inc. will post 1.86 EPS for the current fiscal year.

Healthpeak Properties Dividend Announcement

The firm also recently disclosed a dividend, which will be paid on Friday, May 30th. Stockholders of record on Tuesday, May 20th will be paid a dividend of $0.1017 per share. The ex-dividend date is Monday, May 19th. This represents a dividend yield of 7.05%. Healthpeak Properties’s dividend payout ratio is presently 305.00%.

Analyst Ratings Changes

A number of equities analysts have commented on DOC shares. Wedbush dropped their target price on shares of Healthpeak Properties from $24.00 to $22.00 and set an “outperform” rating on the stock in a research note on Monday, April 28th. Evercore ISI dropped their target price on shares of Healthpeak Properties from $23.00 to $21.00 and set an “outperform” rating on the stock in a research note on Monday, April 28th. Argus restated a “buy” rating and issued a $25.00 target price on shares of Healthpeak Properties in a research note on Tuesday, April 29th. StockNews.com downgraded shares of Healthpeak Properties from a “hold” rating to a “sell” rating in a research note on Thursday, May 1st. Finally, Scotiabank dropped their target price on shares of Healthpeak Properties from $23.00 to $21.00 and set a “sector outperform” rating on the stock in a research note on Monday, May 12th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and nine have assigned a buy rating to the stock. According to MarketBeat.com, Healthpeak Properties currently has an average rating of “Moderate Buy” and a consensus price target of $23.45.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.